Azulene Labs has secured $3.4 million in a pre-seed round led by Ground State Ventures, with participation from Entrada Ventures, to fundamentally reshape molecular discovery. The startup aims to deliver the precision of engineering to the traditionally imprecise field of chemistry, building AI models constrained by the laws of physics.
“An airplane is specified down to manufacturing tolerances before anyone builds a prototype,” says Azulene Labs co-founder Nicolas Sawaya; “Chemistry has had nothing like this. Until now.” The company reports its technology achieves around 100 times the efficiency of competitors while being at least 200 times more cost-effective.
Quantum-Mechanical AI for Precise Molecular Modeling
Azulene Labs uses quantum-mechanical training data to generate AI models for molecular discovery, achieving higher accuracy with the same capital expenditure as conventional methods. This approach circumvents a longstanding challenge in chemistry where predictions of drug-target binding affinity often deviate by a factor of one hundred or more, even after decades of computer modeling advancements. The core innovation lies in constraining AI models to adhere to the laws of physics, a feature absent in many current AI-based chemistry tools that can generate inaccurate or physically impossible molecular structures.
This focus on physical realism allows Azulene Labs to move beyond trial-and-error chemistry toward computational design, a change mirroring practices in fields like aerospace engineering. “A skyscraper is load-tested in simulation before a single beam goes up. These ‘macroscopic’ models are so accurate that you can put enormous trust in them. Chemistry has had nothing like this.
Until now.” This increased predictive power has implications across multiple industries, potentially unlocking solutions for previously intractable problems. Sawaya envisions new cancer medicines targeting proteins considered undruggable, novel antibiotics to combat resistant infections, and sustainable alternatives to toxic industrial solvents currently used at a megaton scale.
The company also targets the development of plastics that maintain performance characteristics while fully degrading after use, addressing the persistent issue of plastic pollution. “Imagine cancer medicines aimed at proteins the industry wrote off as undruggable decades ago,” Sawaya explains, outlining the potential impact of more accurate molecular modeling. Ground State Ventures led the $3.4 million pre-seed funding round, with participation from Entrada Ventures, recognizing the potential for Azulene Labs to redefine chemical and biochemical modeling.
Ton van’t Noordende, founder and General Partner at Ground State Ventures, highlighted the strong alignment between the company’s founders and the market need. “What we see in this company is exceptional founder-market fit at a time when the pharma market is hungry for exactly what this incredible team is building,” he said.
“Nicolas is the perfect person to lead Azulene Labs to become the Anthropic of chemistry.” Azulene Labs’ team comprises scientists holding PhDs from institutions including Caltech, Harvard, UC Berkeley, Columbia, and MIPT, bringing a diverse range of expertise to the challenge. Sawaya himself previously led quantum algorithm development for chemistry at Intel Labs, further solidifying the company’s foundation in both quantum computing and chemical physics.
The company is currently collaborating with early adopters in the biotech and industrial chemistry sectors, applying its technology to real-world challenges and refining its models based on practical feedback. “Chemistry should work the way aerospace engineering already works, where you design the thing in a computer, you believe the answer, and the physical object behaves as predicted the first time you build it,” Sawaya stated, encapsulating the company’s ambition to transform chemistry from an iterative process into a predictable science.
Imagine cancer medicines aimed at proteins the industry wrote off as undruggable decades ago; new antibiotics for infections that have stopped responding to everything we have; replacements for the solvents the chemical industry runs on by the megaton, many of which are toxic enough that regulators are phasing them out with no good substitute yet found, or plastics that perform like the ones we use today but break down completely afterward instead of persisting for centuries.
Nicolas Sawaya, Co-founder at Azulene Labs
See today’s quantum computing news on Quantum Zeitgeist for the latest breakthroughs in qubits, hardware, algorithms, and industry deals.
